ATEX earnings analysis
What we found in ATEX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Anterix delivered a mixed quarter: diluted EPS of $0.01 exceeded the $(0.25) consensus estimate, while $1.958 million of revenue missed consensus by $19,200. Operating cash flow improved by $5.185 million year over year to $2.045 million, and liquidity remained strong with $116.0 million of cash and no debt. The filing provided no new EPS or revenue guidance; approximately $9.6 million of customer proceeds are expected during the remainder of fiscal 2027, but timing remains unpredictable. The filing states that there were no material changes to the risk factors disclosed in the 2026 Annual Report.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- EPS beat consensus
- Diluted EPS was $0.01, a $0.26 beat versus the $(0.25) consensus estimate. The result was also below the prior reported quarter’s $0.98 diluted EPS.
- Revenue grew but missed estimate
- Revenue was $1.958 million, $19,200 below the $1.9772 million consensus estimate, but increased year over year from the prior reported period.
- Operating cash flow improved
- Operating cash flow improved to $2.045 million from $(3.140) million year over year, a $5.185 million improvement.
- Strong cash and debt-free balance sheet
- Cash and cash equivalents were $116.0 million, and the company reported no debt, supporting liquidity for continued spectrum commercialization.
- Customer proceeds remain a catalyst
- Approximately $9.6 million of customer proceeds are expected during the remainder of fiscal 2027, although management noted that the timing of customer proceeds is unpredictable.
- Gross margin remained elevated
- Gross margin was 100.0% in the reported quarterly history, consistent with the company’s asset-light revenue model.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Customer payment timing
- Management states that the timing of customer proceeds is unpredictable; approximately $9.6 million is expected during the remainder of fiscal 2027, creating potential cash-flow and commercialization timing risk.
- Interest income sensitivity
- The company’s primary market-risk exposure is interest-income sensitivity; a 10% change in market interest rates is not expected to materially affect results, but lower rates could reduce interest income on the $116.0 million cash balance.
- Repurchase capacity remains unused
- The company’s $250.0 million share-repurchase authorization had $226,672 of remaining capacity at June 30, 2026, but no shares were repurchased during the quarter. Capital allocation is dependent in part on unpredictable customer-contract proceeds.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.01
- Gross margin
- 100.0%
What they said about what is next.
No numeric revenue or EPS guidance was provided. Management reported approximately $9.6 million of customer proceeds expected during the remainder of fiscal 2027; timing remains unpredictable.
The filing reads about the same as the one before it.
What came before.
- 10-K · June 25, 2026
- Anterix Inc. demonstrated strong financial recovery in FY2026, with net income reaching $90.6 million, an increase of 897% from a loss of $11.4 million in FY2025. The company successfully executed revenue growth of 8%…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ATEX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever